Materialise Stock Price, News & Analysis

Materialise (NASDAQ: MTLS) announced the results of its Extraordinary Shareholders’ Meeting held on November 14, 2025. All proposed resolutions presented at the meeting were approved by the shareholders.

For full voting tallies and additional documentation, investors are directed to the company’s investor website.

Materialise (NASDAQ:MTLS) will hold an Extraordinary Shareholders’ Meeting on Friday, November 14, 2025 at 17:00 CET at its registered office in Leuven and digitally executed by a notary in Ghent.

Agenda items include proposals for share capital movements, a potential buyback program and a new board authorization for buybacks, amendments to the articles of association including the introduction of double voting rights, approval of the remuneration policy, mandating the statutory auditor for sustainability assurance, and confirmation of board composition and director qualifications.

Decisions are partly subject to conditions tied to completion of the listing and other transactions. Documents and convening notices are available on Materialise's website.

Materialise (Nasdaq: MTLS) announced plans for an additional listing of its ordinary shares on Euronext Brussels and an ADS buyback program of up to EUR 30 million. The Euronext listing is expected on or around November 20, 2025 and will complement the existing Nasdaq ADS listing to broaden the investor base and provide liquidity and operational flexibility. The ADS buyback was approved by the board on October 27, 2025, may repurchase approximately 6.1 million ADSs based on the Oct 28, 2025 close, is subject to shareholder approval on November 14, 2025, and is expected to be initiated by no later than January 2026 with execution within 12 months.

Materialise (NASDAQ:MTLS) reported Q3 2025 results for the quarter ended September 30, 2025. Total revenue was 66,259 kEUR, down 3.5% year-over-year but up 2.2% from Q2 2025. Materialise Medical revenue set a quarterly record at 33,296 kEUR, +10.3% YoY. Adjusted EBIT was 2,918 kEUR (4.4% margin) and net profit was 1,848 kEUR (EUR 0.03 per diluted share). Cash and cash equivalents were 132,022 kEUR with gross debt of 64,278 kEUR, producing a net cash position of 67,744 kEUR (increase of 6,724 kEUR since Dec 31, 2024). Full-year 2025 revenue guidance remains 265,000–280,000 kEUR and Adjusted EBIT guidance unchanged at 6,000–10,000 kEUR.

Materialise (NASDAQ: MTLS) will report third quarter 2025 results for the period ended September 30, 2025 on Tuesday, October 28, 2025 at 6:30 a.m. ET / 11:30 a.m. CET. Senior management will host a conference call to discuss results on October 28, 2025 at 8:30 a.m. ET / 1:30 p.m. CET.

Investors can join the call by phone (dial-in details provided via the link at least 15 minutes before start time) or listen to a live audio webcast at http://investors.materialise.com. The webcast will be archived on the company website for later access.

Materialise (NASDAQ:MTLS), a leader in additive manufacturing and medical software, reported mixed Q2 2025 financial results. Total revenue decreased 5.8% to 64,831 kEUR, though the Medical segment grew 16.7%. Gross profit margin improved to 58.3% from 57.0% year-over-year.

The company's Adjusted EBIT improved to 3,058 kEUR from 646 kEUR in Q1 2025 but remained below Q2 2024's 3,872 kEUR. Net profit was 199 kEUR, significantly impacted by unfavorable exchange rates. The company maintains a strong balance sheet with 63,045 kEUR in net cash.

Due to geopolitical volatility and economic uncertainty, Materialise revised its 2025 revenue guidance to 265,000-280,000 kEUR but maintained its Adjusted EBIT guidance of 6,000-10,000 kEUR.

Materialise (NASDAQ: MTLS), a leader in additive manufacturing software and 3D printing services, has scheduled its Q2 2025 earnings release for July 24, 2025 at 6:30 a.m. ET.

The company will host a conference call with senior management to discuss the results at 8:30 a.m. ET on the same day. Participants can access the call through a dial-in option or receive a callback. Additionally, a live audio webcast will be available through the investor relations website, with an archived version accessible afterward.

Materialise (NASDAQ:MTLS), a leading additive manufacturing software and 3D printing solutions provider, has announced its upcoming Annual General Shareholders' Meeting (AGM) scheduled for June 3, 2025, at 10:00 am CET. The company will also hold an Extraordinary Shareholders' Meeting on the same date to vote on proposed amendments to its articles of association. The key proposals include:

- Renewal of Board of Directors' authorization to increase authorized share capital
- Modification of the statutory AGM date starting in 2026

All relevant documents, including the annual report and meeting notices, are accessible on the company's investor relations website.

Materialise (NASDAQ:MTLS) reported Q1 2025 financial results with total revenue increasing 4.3% to 66,379 kEUR, primarily driven by an 18.7% growth in the Medical segment. The company posted a net loss of (535) kEUR or (0.01) EUR per share, compared to a profit of 3,585 kEUR in Q1 2024.

Key metrics include:

• Medical segment revenue up 18.7% to 31,078 kEUR
• Software segment revenue down 6.4% to 9,775 kEUR
• Manufacturing segment revenue decreased 5.5% to 25,526 kEUR
• Adjusted EBIT declined to 646 kEUR from 2,656 kEUR year-over-year
• Net cash position improved by 6,716 kEUR to 67,736 kEUR

The company maintained its FY2025 guidance, expecting consolidated revenue between 270,000-285,000 kEUR and Adjusted EBIT of 6,000-10,000 kEUR, despite ongoing macro-economic and geo-political uncertainties.